Source link : https://www.newshealth.biz/health-news/upadacitinib-user-survey-confirms-eczema-clinical-data/
In a survey of adults with moderate to severe AD participating in a patient support program for upadacitinib in the United States, 86.8% reported that their itch was “very much” or “much” improved from taking the drug, while 7.8% rated their itch as minimally improved. Also, 27.5% reported itch improvement within one day of taking […]
Author : News Health
Publish date : 2024-06-20 06:21:37
Copyright for syndicated content belongs to the linked Source.
Categories